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Abstract: Endoplasmic reticulum (ER) stress, a cellular condition caused by the accumulation of
unfolded proteins inside the ER, has been recognized as a major pathological mechanism in a variety
of conditions, including cancer, metabolic and neurodegenerative diseases. Trefoil factor family
(TFFs) peptides are present in different epithelial organs, blood supply, neural tissues, as well as in the
liver, and their deficiency has been linked to the ER function. Complete ablation of Tff3 expression is
observed in steatosis, and as the most prominent change in the early phase of diabetes in multigenic
mouse models of diabesity. To elucidate the role of Tff3 deficiency on different pathologically
relevant pathways, we have developed a new congenic mouse model Tff3−/−/C57BL6/N from a mixed
background strain (C57BL6/N /SV129) by using a speed congenics approach. Acute ER stress was
evoked by tunicamycin treatment, and mice were sacrificed after 24 h. Afterwards the effect of Tff3
deficiency was evaluated with regard to the expression of relevant oxidative and ER stress genes,
relevant proinflammatory cytokines/chemokines, and the global protein content. The most dramatic
change was noticed at the level of inflammation-related genes, while markers for unfolded protein
response were not significantly affected. Ultrastructural analysis confirmed that the size of lipid
vacuoles was affected as well. Since the liver acts as an important metabolic and immunological organ,
the influence of Tff3 deficiency and physiological function possibly reflects on the whole organism.
Keywords: ER stress; trefoil peptide 3; liver; tunicamycin; proinflammatory cytokines
1. Introduction
Proper protein folding and localization is crucial for protein function. Endoplasmic reticulum
(ER) has the main role in the folding and dispatching of secretory and transmembrane proteins to
the appropriate destinations. Various conditions, such as increased protein synthesis, decreased
ER-associated degradation, disturbed lipid homeostasis, calcium eﬄux and oxidative stress, can lead
to an accumulation of misfolded proteins, and subsequently trigger a condition known as ER stress
(ERS) [1]. The adaptive mechanism activated in this situation is known as the unfolded protein
response (UPR). The central role of the UPR is to restore protein homeostasis, but in case of a prolonged
signal, such as chronic stress and/or severe damage, it can lead to apoptosis. The UPR forms a complex
network mediated by three ER membrane-associated proteins, protein kinase R (PKR)-like endoplasmic
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reticulum kinase (PERK), inositol requiring enzyme 1 alpha (IRE1α) and activating transcription factor
6 alpha (ATF6α).
These signaling pathways change the expression of numerous genes involved in cytokine
production, apoptosis, autophagy, glucose metabolism, folding chaperones and quality control [2]. ERS
is recognized as a major pathological mechanism in a variety of conditions, including metabolic and
neurodegenerative diseases. Its activation can exacerbate inflammatory and oxidative stress signaling
pathways, leading to insulin resistance, fatty liver disease and obesity [3].
Trefoil factory family peptides (TFFs) have been linked to the ER function. Tff1-deficient mice have
been shown to activate UPR in the stomach tissue [4], whilst Tff2-deficient mice exhibit an overexpression
of the transporter associated with antigen processing 1 (Tap1), a protein involved in ER-associated
degradation as well as the overexpression of chaperone Bcl2 associated athanogene 2 (Bag2) in the
pyloric antrum [5]. Screening of the mouse cochlear cDNA library with yeast-two-hybrid assay
identified Bcl2-associated athanogene 6 (Bag6/Bat3/Scythe) as a potential Tff3 interactive partner [6].
Bag6/Bat3/Scythe is a protein complex involved in apoptosis and the quality control of membrane
proteins [7]. The study done on goblet cells analyzed the impact of lactic acid bacteria on intestinal
health, and it demonstrated that tunicamycin (Tm), an inducer of ERS, downregulates the expression
of the Tff3 gene [8]. Furthermore, mice deficient in the protein Oasis, a well-known ERS transducer,
exhibit a significantly increased expression of Tff3 in goblet cells [9]. Tff3 (59 amino acid, 7 kDA),
predominantly expressed in intestinal goblet cells, has a multifunctional role in protecting mucosa by
being involved in cell migration, immune response and apoptosis [10,11].
TFFs’ presence in the bloodstream and in various other organs (lung, pancreas, mammary gland,
inner ear, lymphoid tissue, and even in the brain) points to their general importance in the organism
homeostasis [12]. It has been shown that Tff3 from the liver has neuroprotective and cardioprotective
effects [13,14]. Liver Tff3, induced by ischemic brain injury, can pass the blood-brain barrier, and
concentrate in an affected region, alleviating the damage. Gene expression of Tff3 in the liver is
significantly downregulated in different mouse models of obesity [15,16], diabesity [17] and liver
steatosis [18], conditions that are associated with ER dysfunction.
Considering its expression in various tissues and its multiple biological roles, including a role in
relevant metabolic processes, it is necessary to have a controlled model to elucidate the specific role of
Tff3 protein in different parts of organism. Existing Tff3-deficient mice [19], generated on a mixed genetic
background (C57BL6J/Sv129), have a possible impact of additional mutations and unpredictable genetic
combinations on different genetic loci. We have generated a novel congenic strain on a C57BL6/N
genetic background to avoid, increased genetic heterogeneity [20], a known problem with heterozygous
mixed background strains. Crossing males of the existing mixed background Tff3−/−/C57BL6/J/SV129
strain [19] with C57BL6/N females led to a novel strain deficient in Tff3 protein, while the rest of the
genome is homozygotic, as in the wild type C57BL6/N strain. The C57BL6/J sub-strain has various
mutations, including deletion within the nicotinamide nucleotide transhydrogenase (Nnt) gene, which
causes an altered metabolic phenotype (https://www.jax.org/strain/000664) [21]. Hence, this C57BL6/N
substrain is a more representative model for metabolic studies.
The aim of the present study was to develop a congenic Tff3-deficient mouse strain without
any additional metabolically-relevant mutations, and to assess the impact of Tff3 deficiency on
disease-related genes (ERS, oxidative stress and inflammation relevant genes) in the liver, as a major
metabolic organ. Mice were exposed to acute ERS induced by Tm, a drug that blocks the initial step of
N-glycosylation, leading to accumulation of misfolded proteins in the ER. Effects of acute ERS were
monitored in the liver at the relevant gene/protein expression levels, which were shown to play roles
in ERS and oxidative stress signaling, expression of inflammatory genes, and have an impact on the
ultrastructural level.
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2. Results
2.1. Expression of ER Stress Markers
To analyze the effect of Tff3 deficiency on ER stress in the liver, we monitored expression levels of
the relevant ERS genes (Figure 1) and proteins (Figure 2) in wild type and Tff3-deficient, Tm-treated
mice (Wt Tm and Tff3−/− Tm), as well as untreated controls (Wt CTR and Tff3−/− CTR). Liver tissue was
collected 24 h after treatment. Using the SYBR green quantitative polymerase chain reaction (qPCR)
method, we compared the levels of several ERS relevant genes: BIP, GRDP94, CHOP, sXBP1, EDEM
and ATF4. Comparison of gene expression relative to Wt CTR mice (Figure 1A) showed that Tm
treatment activated relevant ERS marker genes, which was statistically relevant and comparable in both
mice genotypes. Tm-treated Wt and Tff3−/− mice showed a similar gene expression level (Figure 1B).
Tff3−/− mice had slightly reduced levels of the ERS marker genes, although this was not statistically
significant. Protein levels of PERK and eIF2α and their activated phosphorylated forms were similar
in Wt and Tff3−/− mice (Figure 2).
2.2. Expression of Oxidative Stress Marker Genes
The effect of Tff3 deficiency on the oxidative stress markers (Figure 3) was monitored in the livers
of Wt and Tff3−/− mice with and without Tm treatment. Gene expression levels relative to untreated
Wt mice showed that Tm treatment statistically reduced the expression of GPX1 in Wt (4.55 fold) and
Tff3−/− (3.5 fold) mice.
Expression of other marker genes (SOD3, NOX2, COX1 and SOD1) was not affected (Figure 3A).
Tm-treated Tff3−/− mice, compared to Wt Tm-treated mice, revealed a significantly increased expression
level of COX1 (1.65 fold) and GPX1 (1.35 fold) (Figure 3B).
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Figure 1. Effect of tunicamycin treatment on the expression of ER stress markers. We performed a
quantitative polymerase chain reaction (qPCR) using SYBR green detection chemistry for each group
(n = 5 animals per group), wherein Ct data were analyzed by REST software and presented relative to
the Wt control group as log2 (fold change) (A). Additionally, expression of genes in tunicamycin-treated
trefoil factor family 3 (Tff3)−/−mice was expressed relative to Wt tunicamycin-treated mice (B). ** p ≤ 0.01,
*** p ≤ 0.001; Wt Tm = wild type tunicamycin-treated mice, Tff3−/− CTR = Tff3-deficient untreated mice,
Tff3−/− Tm = Tff3−/− tunicamycin-treated mice.
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Figure 3. Effect of tunicamycin treatment on the expression of relevant oxidative stress genes in Wt- and
Tff3-deficient mice. We performed qPCR using SYBR green detection for each group (n = 5 animals per
group), Ct data were analyzed by the REST program and presented relative to Wt control (A). Expression
of genes in tunicamycin-treated Tff3-deficient mice was expressed relative to Wt tunicamycin-treated
mice (B). * p ≤ 0.05; Wt Tm = wild type tunicamycin-treated mice, Tff3−/− CTR = Tff3 deficient untreated
mice, Tff3−/− Tm = Tff3−/− tunicamycin-treated mice.
2.3. Tff3 Deficiency Reduces Cytokine Expression in Acute ERS
Both Wt and Tff3−/− mice showed an upregulation of liver cytokine gene expression upon ERS
induction: CXCL1 (60.67 fold), IL6 (50.25 fold), MCP1 (7.40 fold), IL1β and TNFα (5 fold). IL1α and
TGFβ were not affected (Figure 4A). Tff3−/− Tm mice had a statistically relevant reduced expression of
CXCL1 (3.43 fold), MCP1 (2.87 fold) and IL1β (2.15 fold) compared to Wt Tm mice (Figure 4B). MCP1
and CXCL1 protein levels were monitored by Western bl t analysis (Figure 5), but protein levels did
not reveal the differenc obs ved at he mRNA level (Figure 4B).
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Figure 4. Effect of tunicamycin treatment on the expression of cytokine genes in Wt and Tff3-deficient
mice. We performed qPCR using SYBR green detection for each group (n = 5 animals per group),
Ct data were analyzed by REST program and presented relative to Wt control as log2 (fold change)
(A). Expression of genes in tunicamycin-treated Tff3−/− mice was expressed relative to the Wt
tunicamycin-treated mice (B). * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001; Wt Tm = wild type tunicamycin-treated
mice, Tff3−/− CTR = Tff3 deficient untreated mice, Tff3−/− Tm = Tff3−/− tunicamycin treated mice.
2.4. Shotgun Proteomic Analysis of Liver Proteome ERS Provoked WT and Tff3 Deficient Mice
Comparing the global protein expression levels of Tm-treated Wt and Tff3-deficient mice, a
difference between the groups is shown (Figure 6). Tff3−/− mice livers had changed the expression of
antioxidative proteins involved in the resolution of Tm-induced oxidative stress. Metallothionein-1
(MT1) and metallothionein-2 (MT2) had a 2-fold increase in level, while glutathione S-transferase pi
1 (GSTP1) and glutathione S-transferase I pi 2 (GSTP2) had a 3-fold level reduction. Applying an
additional statistical approach using false discovery rates (FDR) that compensated for large data sets,
these changes did not reveal any relevant statistical reliability (Data in Supplement: Table S1).
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examined hepatocytes were affected. No histomorphological differences were observed between the
two groups. No fibrosis or signs of inflammation were detectable. Cryosections of the same livers
stained with Oil Red O supported this result, revealing numerous lipid droplets in hepatocytes stained
intensively red. Semi-quantitative analysis of the share of lipid droplet area showed no statistically
significant difference between the groups; median share of lipid droplets for the Wt and Tff3−/− groups
was 56.42 and 59.63%, respectively (p = 0.75, Mann-Whitney U test).
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Figure 7. Liver tissue of wild type (A,C) and Tff3 knock-out (B,D) tunicamycin-treated mice stained
using hematoxylin-eosin (A,B) and oil red O (C,D). Numerous small lipid droplets (marked with black
→) are visible in the cytoplasm of hepatocytes stained using hematoxylin-eosin. There is no apparent
morphological difference in fatty changes between the two groups. On oil red O-stained slides, lipid
droplets stained intensively red are abundant in hepatocyte cytoplasm across the slide. There is no
apparent morphological difference in fatty changes between the two groups. Scale bar: 60 µm.
Analysis of ultrastructure (Figure 8) showed no changes in the morphology of the hepatocytes or
capillaries. Liver cells demonstrated normal cell bodies with dense and round nuclei and moderate
amounts of cytoplasm. No accumulation of autophagosomes, lysosomes or peroxisomes was detected.
Kupffer cells were counted, and a comparable amount of liver macrophages were found in control and
Tff3−/− mice. General morphology of mitochondria appeared to be normal, including inner and outer
mitochondrial membranes. Mitochondria were often surrounded by rough endoplasmic reticulum
(RER) in both Tff3−/− and Wt animals. Fat vacuoles in the cytoplasm of the hepatocytes were found to
be visibly enlarged in Tff3−/− mice (Figure 8).
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3. iscussion
Unresolved ERS underlies various pathological changes in different organs, and its activation
is associated with metabolic diseases like obesity, type 2 diabetes (T2D) and nonalcoholic fatty liver
disease ( AFLD) [22–24]. Exact echanis s of interaction bet een ERS and etabolic disruption
are not yet fully understood. Liver, as an i portant etabolic organ, regulates blood glucose and
synthesizes fatty acids fro glycolytic products in the process of de novo lipogenesis [25]. Co plete
loss of Tff3 expression was the most prominent expressional change during the early stages of diabetes
in the liver of the polygenic mice model of diabesity [17], and since then its role in relevant metabolic
processes has emerged [15,16]. Hence, our goal was to investigate the impact of Tff3 deficiency on
relevant ER, oxidative stress and inflammation pathways, which are the key mechanisms in the
development of pathological changes in the liver. Since Tffs-deficient mouse models show evidence
of disturbed protein processing and possible interaction with chaperones [4–9], we have compared
the effect of acute ERS in the liver of novel, congenic, Tff3-deficient mice and relevant wild type
control. ER stress was induced by Tm, a drug shown to successfully mimic hepatic steatosis [26].
Activation of the UPR was monitored by qPCR analysis of downstream targets of UPR. Analyzed
genes are common genes used to examine UPR activation: endoplasmic reticulum chaperone BIP (BIP),
activating transcription factor 4 (ATF4), DNA damage-inducible transcript 3 (CHOP), ER degradation
enhancing alpha-mannosidase like protein 1 (EDEM1), heat shock protein 90 (GRP94) and spliced
X-box binding protein 1 (sXBP1) [27]. Upon perturbance in protein folding, BIP dissociates from the
three key master regulators of UPR, i.e., IRE1, PERK and ATF6, and consequently activates them.
ATF4 and CHOP are transcription factors activated in the PERK signaling pathway. ATF4, amongst
other functions, plays a distinct role in autophagy resulting from Tm-induced ERS [28], while CHOP
has a complex proapoptotic role [24]. In response to ERS, IRE1 cleaves XBP1, resulting in sXBP-1, an
active UPR transcription factor which exerts strong pro-survival effects under various conditions [29].
EDEM1 is an ER-associated protein degradation (ERAD) chaperone [30], and GRP94 performs unique
chaperone functions in the ER [31]. Additionally, we analyzed UPR activation on the protein level by
measuring PERK activation with a phospho-specific PERK antibody, as well as the phosphorylation of
its downstream target eukaryotic translation initiation factor 2 alpha (eIF2α).
Results showed that an activation of analyzed UPR markers does not statistically differ in
7-week-old male Tff3−/− mice, compared to the relevant wild type control on transcriptional and protein
levels (Figure 1). It seems that Tff3 deficiency does not have a significant effect on the expression of the
key components of the UPR pathway in Tm-induced acute ERS.
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Oxidative protein folding in endoplasmic reticulum is an important resource of reactive oxygen
species (ROS) production. Some evidence suggests that endoplasmic reticulum has antioxidant
protection that may not be sufficient to relieve the oxidative stress caused by increased protein
folding [32]. Tff3 was linked to oxidative stress in human tumor cells, where it was upregulated
in the late phase of response to oxidative stress caused by X-rays [33]. Glutathione peroxidase 1
(GPX1) is an antioxidant enzyme [34] expressed ubiquitously in the mitochondria and cytoplasm
of many tissues. Wild type and Tff3−/− Tm-treated mice show a statistically significant reduction in
the expression of GPX1 (4.55 and 3.5 fold, respectively) compared to Wt untreated mice (Figure 3A).
Tff3−/− Tm-treated mice have a slightly but significantly higher expression level of GPX1 (1.35 fold)
relative to Wt Tm-treated mice (Figure 3B). Previous reports showed no significant difference in liver
GPX1 expression between WT and Tff3−/− mice of mixed background in control condition similar as in
this new strain background [35]. GPX activity in NAFLD livers compared to control is significantly
higher [36] and the severity of disease is correlated with the decreased activity of GPX [37].
Cyclooxygenase 1 (COX1) is an enzyme located in the endoplasmic reticulum and nuclear envelope
of a wide variety of cells and tissues. It forms prostaglandins via arachidonic acid oxygenation by a
free radical mechanism [38], hence, it may produce toxic oxygen species [39]. Expression of COX1 is
essential for hepatic homeostatic maintenance [40]. Both Tff3 and COX-1 take part in the protection of
intestinal mucosa and promotion of cell migration [41,42].
While Tff3 regulates gastric epithelial restitution via a COX1 independent pathway [43],
the activation of cellular invasion by Tff3 is mediated by a COX1 dependent signaling pathway [42].
Tff3−/− untreated animals show a slightly higher expression of COX1 than untreated wild type animals
(Figure 3A), and Tm-treated animals reveal a significant difference (Figure 3B), indicating the impact
of Tff3 deficiency on COX1 expression in acute ERS. Xiao et al. found that deficiency or inhibition of
COX-1 during acute liver injury, increased hepatic oxidative stress, inflammation and apoptosis in
mice. Specifically, they showed a higher expression of MCP-1 and IL-1β [40]. The similar situation
regarding the expression of previously mentioned genes is in accordance with our results (Figure 3A,B
and Figure 4A,B). Tff3 protein has been found to be upregulated in forms of intestinal inflammation,
which is the site of its predominant expression. It is also synthesized in lymphoid tissues (spleen,
thymus, lymph nodes, bone marrow), and it stimulates migration of monocytes, which suggests a
potential role in the immunological response to tissue injury [44]. Furthermore, it is demonstrated that
Toxoplasma gondii-infected, Tff3-deficient mice, show a significantly down-regulated expression of IFN
γ, IL-12, IL-1β and TNFα, involved in the inflammatory response [45].
ERS leads to the production of various pro-inflammatory molecules [46] and Tm treatment causes
a strong increase in the expression of CXCL1 (60.67 fold), IL6 (50.25 fold), MCP1 (7.40 fold) in the liver
of both Wt and Tff3−/− mice. Tff3−/− mice have significantly reduced levels of several proinflammatory
cytokines (downregulated CXCL1: 3.43 fold; MCP1: 2.87 fold and IL-1β: 2,15 fold) compared to the
wild type (Figure 4B), indicating a diminished inflammatory response in the case of Tff3 deficiency.
As mentioned before, IL-1β was also found to be downregulated in the ileum of Tff3−/− mice infected
by Toxoplasma gondii [45].
Immune cells and hepatic inflammation have a central role in the pathogenesis of metabolic
disease, and chemokines are crucial immune cells in the regulation and activation of hepatocytes and
circulating immune cells [47]. MCP1 is an important CC-chemokine, involved in the recruiting and
activation of immune cells to the site of tissue injury [48]. Transgenic mice overexpressing MCP1
demonstrate insulin resistance and increased hepatic triglyceride content in adipose tissue, suggesting
a significant role of MCP1 in the hepatic steatosis of early liver injury [49]. Mandrekar et al. show that
MCP1−/− mice have reduced steatosis in alcoholic liver injury, and they also demonstrate that MCP1 in
the liver regulates macrophage activation and proinflammatory cytokines [50].
CXCL1 is a chemokine expressed in macrophages, epithelial cells and neutrophils with a key
role in neutrophil recruitment and activation [51]. It is known that hepatic neutrophil infiltration,
a symptom of steatosis, is linked with various liver pathological conditions via mechanisms of
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generating reactive oxygen species (ROS) and the production of pro-inflammatory mediators [52].
Wang et al. show that inhibition of CXCL1 did reduce hepatic neutrophil infiltration, and consequently
ameliorated steatohepatitis in a mice model of disease. IL-1β signaling can exacerbate an accumulation
of cholesterol [53] and triglyceride [54] in the liver. Moreover, IL-1β-deficient mice during NAFLD had
reduced inflammation and steatosis in the liver [55].
The changes noticed at the level of gene expression were not followed at the protein level. Western
blot showed unchanged levels of MCP1 and CXCL1 protein. This could be explained by the differential
dynamics of the mRNA and the complex relationship in concentrations of mRNAs and proteins during
misfolding stress, having a peak between 2–8 h upon ERS induction [56], and we have monitored the
effects 24 h upon treatment. Thus far the role of Tff3 protein in immune processes is not thoroughly
known. Our data suggest that Tff3-deficient mice have less ability to start a pro-inflammatory cascade
in acute ERS.
Total proteome analysis distinguishes two different sample types. Changes were found at the
level of antioxidative proteins that are involved in the resolution of Tm-induced oxidative stress in the
liver of Tff3-deficient mice. MT1 and MT2 have a 2-fold increase in levels, while GSTP1 and GSTP2
have a 3-fold level reduction. Metallothioneins are cysteine-rich, heavy metal-binding proteins with
antioxidant properties [57]. They are involved in DNA protection, oxidative stress, angiogenesis
and apoptosis [58], and hepatic metallothionein expression seems to have a protective role in liver
pathology [59]. Decreased expression of MT1 and MT2 in the liver is associated with liver steatosis
in high fat diet-induced, obese mice [60]. In line with our findings, Kondoh et al. found that the Tm
treatment enhanced the hepatic MT levels in C57BL/6J mice [61].
Metallothionein-1G overexpression in human colorectal cancer cells HT-29 considerably enhances
the induction of Tff3 [62]. Gluthatione S-transferases play a role in cell defense against oxidative stress
and are involved in liver pathologies [63]. GSTP was identified as an ER-resident protein, where
it demonstrates both chaperone and catalytic functions. Glutathionylation of multiple ER-resident
proteins is vital for ER homeostasis and UPR, and it impacts cell sensitivity to ERS-inducing drugs,
like Tm [64]. It can also interfere with ERS-induced apoptosis.
Applying a specific large database statistical approach called false discovery rate (FDR) analysis
that normalizes large data sets, we observed no statistically significant changes between Tm-treated
Wt and Tff3-deficient mice 24 h upon treatment.
Tm-induced ERS causes hepatic steatosis via the upregulation of a very low-density lipoprotein
receptor (VLDLR) and consequently increases lipoprotein delivery to the liver [65]. It also disturbs
lipid metabolism and the accumulation of fat in a form of numerous small lipid droplets in hepatocytes
that is evident in Wt and Tff3-deficient mice liver (Figure 7). Our histological approach applying
hematoxylin-eosin and oil red O staining did not reveal obvious differences between the groups.
However, ultrastructural analysis revealed that ERS provoked Tff3-deficient mice have slightly enlarged
fat vacuoles compared to wild type mice (Figure 8). This finding is consistent with results from a
former study where Guillén et al. showed a decreased Tff3 gene expression in mice with a stronger
extent of liver steatosis [18]. Our findings in the liver of mixed background Tff3−/− mice on a normal
diet show that fat vacuole formation was also affected [35]. Ultrastructural analysis of the liver tissues
show no difference in a number of immunologically relevant cells, and no difference in the general
morphology of mitochondria, hepatocyte cell bodies, cytoplasm or capillaries between Tm-treated
Tff3−/− mice and Wt control mice.
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4. Materials and Methods
4.1. Experimental Animals
A novel congenic Trefoil factor family 3 (Tff3)-deficient mouse strain on C57BL6/NCrl (Charles
River) background was developed from an existing Tff3-deficient mixed background strain
(C57BL6/J/SV129) [19] using a ‘speed congenics’ approach. Mixed background Tff3−/− males were
crossed with C57BL6/NCrl females, and heterozygote Tff3−/− males were detected and analyzed for
500 SNP polymorphisms (ENVIGO) to identify the Tff3-/+ male closely resembled to the C57BL6/NCrl
strain. This approach was used for five consecutive back crossings to identify the male carrier with
100% similarity to the C57BL6/NCrl strain regarding relevant SNP loci. Resulting offspring were set
up to mate according to a brother x sister scheme, homozygous Tff3−/− male and female mice (F0
generation) were identified and used to start breeding a new Tff3−/−/C57BL6/NCrl strain. This new
congenic Tff3−/− mice and wild type mice (C57BL6/NCrl) differ only in the Tff3 region and a small
surrounding fragment inherited from the embryonic cell of SV129 strain, while the rest of the genetic
loci are homozygous. Thus, we can be more confident that the observed phenotype is a consequence
of inactivated Tff3 protein. Male mice of Tff3−/−/C57BL6/NCrl and the related C57BL6/NCrl wild
type strain were used for all further experiments. Animals were kept under standard care conditions.
Experimental animal manipulations and procedures performed in course of the Croatian Science
Foundation grant IP-06-2016-2717 were approved by the local ethical committee.
4.2. Inducing ER Stress
Acute ERS was induced by a single injection Tm treatment. Stock Tm solution was prepared in
sterile dimethyl sulfoxide (DMSO) (10 µg/mL) and diluted with 150 mM dextrose. Tm (3 µg of Tm/g of
mouse body weight in a 300 µL final volume) was administered intraperitoneally to Tff3-deficient and
wild type mice that were seven weeks old. Control animals received 300 µL of 150 mM dextrose. Mice
were sacrificed and their tissue was harvested for further analysis after 24 h. During that time food
and water were available ad libitum.
4.3. Quantitative PCR
Total RNA was isolated from the livers of Tff3−/− mice and Wt controls using an RNeasy Mini
Kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions. 1.5 µg of RNA was
transcribed into cDNA with a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Dreieich, Germany). We performed a quantitative polymerase chain reaction (qPCR) using SYBR
Green I (Invitrogen, Waltham, MA, USA) detection chemistry and specific primers (Table 1) on the
StepOnePlus™ qPCR System (Applied Biosystems). The cycling conditions comprised three min
polymerase activation at 95 ◦C and 40 cycles, including 95 ◦C for 1min, annealing temperature specific
for each primer pair (Table 1) for 30 s, and elongation at 72 ◦C for 30 s. A single product amplification
was confirmed by melting curve analysis. Gene expression was analyzed by REST © software (∆∆Ct
method) and normalized to stable housekeeping genes, β-actin (ACTβ) and β2-microglobulin (B2M).
Changes were represented as log2 (fold change).
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Table 1. Oligonucleotides used for qPCR analysis.
Gene Symbol Accession No. Primer Sequence Forward (5
′-3′) Reverse
(5′-3′)
Optimized qPCR Conditions
(Annealing Temp/MgCl)
ERS markers
ATF4 NM_009716.3 CCACTCCAGAGCATTCCTTTAGCTCCTTTACACATGGAGGGATTAG 59
◦C; 3.5 mM
BIP NM_001163434.1 GAGACTGCTGAGGCGTATTTCAGCATCTTTGGTTGCTTGTC 58
◦C; 3.5 mM
CHOP NM_007837.4 TTGAGCCTAACACGTCGATTATCACTTCCTTCTGGAACACTCTC 58
◦C; 3 mM
EDEM NM_138677.2 TGAAAGCATGTGAGGGTAGTGGAGAGAAGGGAAGACAGGATAGA 61
◦C; 3.5 mM
GRP94 NM_011631.1 AAGAATGAAGGAAAAACAGGACAAAACAAATGGAGAAGATTCCGCC 58
◦C; 3 mM
sXBP1 NM_008934.4 GAGTCCGCAGCAGGTGGTGTCAGAGTCCATGGGA 56
◦C; 3 mM
Cytokines
CXCL1 NM_008176.3 GTGTCAACCACTGTGCTAGTCACACATGTCCTCACCCTAATAC 61
◦C; 3.5 mM
IL1α NM_010554.4 CCTTACACCTACCAGAGTGATTTCCTTACACCTACCAGAGTGATTT 65
◦C; 3 mM
IL1β NM_008361.4 ATGGGCAACCACTTACCTATTTGTTCTAGAGAGTGCTGCCTAATG 64
◦C; 3 mM
IL6 NM_031168.2 GATAAGCTGGAGTCACAGAAGGTTGCCGAGTAGATCTCAAAGTG 59
◦C; 3.5 mM
MCP1 NM_011333.3 CCTGGATCGGAACCAAATGACGGGTCAACTTCACATTCAAAG 62
◦C; 3 mM
TGFα NM_031199.4 CTTTAGGAAGGACCTGGGTTGGTGTGTCCAGGCTCCAAATA 66
◦C; 3 mM
TNFα NM_013693.3 GTCTCAGAATGAGGCTGGATAAGCATTGCACCTCAGGGAAGAA 63
◦C; 2.5 mM
Oxidative stress markers
COX1 NM_008969.4 GTGCCAGAACCAGGGTGTCTGTAGCCCGTGCGAGTACAATC 58
◦C 3 mM
GPX1 NM_008160.6 GGTTCGAGCCCAATTTTACACATTCCGCAGGAAGGTAAAG 58
◦C 2.5 mM
NOX2 NM_007807.5 ACTCCTTGGGTCAGCACTGGGTTCCTGTCCAGTTGTCTTCG 62
◦C 3 mM
SOD1 NM_011434.2 GCCTTCTGCTCGAAGTGGATGGAAGCATGGCGATGAAAGC 59
◦C 3.5 mM
SOD3 NM_011435.3 TGGCTGATGGTTGTACCCTGTGAGAAGATAGGCGACACGC 60
◦C 2.5 mM
Housekeeping genes
ACTB NM_007393.5 GCAAGCAGGAGTACGATGAGCCATGCCAATGTTGTCTCTT 61
◦C; 3.5 mM
B2M NM_009735.3 CCTGCAGAGTTAAGCATGACAGTTCATGATGCTTGATCACATGTCT 60
◦C; 3 mM
4.4. Western Blot
Liver proteins were isolated from Tm-treated Tff3−/− (n = 5) and Wt mice (n = 5) using RIPA
buffer (50 mM TRIS HCL, pH8, 150 mM NaCl, 1 mM EDTA, 1% NP40, 1% sodium deoxycholate,
0.1% SDS) supplemented with phosphatase and protease inhibitors (Roche, Basel, Switzerland). Total
protein concentration was determined by a BCA protein assay kit (Pierce, ThermoFischer, Waltham,
MA, USA) and 25 µg of proteins per lane was separated by Sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE). Proteins were transferred to a nitrocellulose (ERS markers) or PVDF
membrane (cytokines), blocked with 5% BSA in TBS-T and incubated overnight at 4 ◦C with primary
antibodies. The following monoclonal antibodies were used: Anti-(PKR)-like endoplasmic reticulum
kinase (PERK) (#3912), anti-phospho-PERK (#3179), polyclonal anti-eIF2α (#9722) and anti-phospho
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eIF2α (#9721) antibodies from Cell Signaling Technology at dilution 1:1000 in 5% BSA/TBST. Cytokines
were detected using rabbit anti-MCP-1 at 1:500 dilution (A00056-4) and anti-CXCL1 at 1:8.000 dilution
(A00533) (Boster Biological Technology, Pleasanton, CA, USA) by incubation overnight at 4 ◦C.
The following secondary antibodies were used for detection, that is, goat anti-rabbit IgG-HRP antibody
(#170-6515; Bio-Rad, Hercules, CA, USA) or goat anti-rabbit IgG -HRP (#170-6515; Bio-rad). The chemo
luminescence signals were detected (Alliance 4.7 Imaging System UVITEC, Cambridge) and analyzed
with Image J. Amido Black staining was used as loading control and for the normalization of the bands.
4.5. Proteomic Analysis
4.5.1. Protein Extraction and Sample Preparation
Proteins from the tissue were extracted using a Minute Kit according to manufacturer’s instructions.
The total protein concentration in lysates was determined using a BCA protein Assay (Thermo Scientific,
Rockford, Waltham, MA, USA). The internal standard was prepared by pooling all samples used in
the study (equal protein amounts). TMT labeling was performed as described [66]. Shortly, 30 µg of
proteins was diluted with 0.1 M triethyl ammonium bicarbonate (TEAB, pH 7.8 (slightly alkaline) up
to a final volume of 50 µl. Samples were reduced (2.5 µL of 200 mM DTT, 1 h at 55 ◦C, alkylated (2.5 µL
of 375 mM IAA, 30 min at room temperature in the dark) and acetone-precipitated (six volumes of
ice-cold acetone, −20 ◦C overnight). After centrifugation (8000× g, 10 min at 4 ◦C), 50 µg of pellets
were dissolved in 50 µL of 0.1 M TEAB and trypsin digested (1:40, w/w) at 37 ◦C overnight. Tryptic
peptides were labeled using TMT tenplex reagents (Thermo Scientific, Rockford, Waltham, MA, USA)
which were prepared according manufacturer’s instructions. An amount of 19 µL was added to each
sample for the labeling reaction (60 min, RT), which was quenched using 5% hydroxylamine (15 min,
RT). Four TMT-labeled peptide samples were combined with the internal standard into the new tube,
aliquoted, dried and stored at −80 ◦C for further analysis.
4.5.2. LC-MS/MS Analysis
High-resolution LC-MS/MS analysis was performed for protein identification and relative
quantification as previously reported [66]. In short, prior to analysis, dried TMT-labeled peptides were
dissolved in loading buffer (2% ACN in 0.1% FA) and an amount of 1 µg was desalted on the trapping
column by employing the Ultimate 3000 RSLCnano system (Dionex, Germering, Germany). Peptides
were then separated using PepMap™ RSLC C18 (50 cm × 75 µm ID) column during 2 h linear gradient
of 5–35% buffer B (0.1% FA in 80% ACN) at a flow rate of 300 nL/min. Nanospray Flex ion source and
stainless steel emitter (New Objective, Woburn, MA, USA) was used. The ionization voltage was set to
2.1 kV, and the ion transfer tube temperature at 250 ◦C. DDA was performed in a positive ion mode
using the Top 8 method, using Q Exactive Plus (Thermo Scientific, Bremen, Germany). Full scan FTMS
spectra were acquired in a mass range m/z 350.0 to m/z 1900.0 with a resolution of 70,000, AGC target
1 × 106, and the maximum injection time 110 ms. For MS/MS scan, step collision energy was set to 25,
35 and 40% NCE with resolution 17,500 and AGC target 2 × 105. An isolation window of ± 2.0 Da was
applied to isolate precursor ions with dynamic exclusion of 30 s.
4.5.3. Data Analysis
A database search was performed using the SEQUEST algorithm implemented into Proteome
Discoverer (version 2.3., Thermo Fisher Scientific) against Mus musculus FASTA files (NCBI database,
downloaded 7/12/2017, 46105 entries) according the following parameters: two trypsin missed cleavage
sites, precursor and fragment mass tolerances of 10 ppm and 0.05 Da, respectively; carbamidomethyl
(C) as a fixed peptide modification, oxidation (M) and TMT sixplex (K, peptide N-terminus) as dynamic
modifications. The FDR for peptide identification was calculated using the Percolator algorithm within
Proteome Discoverer workflow, based on the search results against a decoy database. At least two
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unique peptides and 5% FDR were set to obtain reliable protein identification. For the reporter-based
relative quantification, an internal standard was used to compare the data between the experiments.
All statistics was performed using R v3.2.2 [67]. Proteins with 100% missing data were removed
from the analysis. Sample outliers were detected per each group for each of the proteins using the
Dixon’s test from R package outliers v0.14 [68]. If any sample outlier was significant (p > 0.05) it
was removed from further analysis. To test the difference in protein abundance between groups, the
Wilcoxon-Mann-Whitney test was performed. Fold change between two groups was calculated as
mean (Group2)/mean (Group1) and expressed on log2 scale. PCA and volcano plots were designed
using R package ggplot2 v3.1.1 [69]
4.6. Histology
Liver tissue was fixed in 4% paraformaldehyde; half of it was paraffin-embedded, and the other
part cryo-protected in sucrose, frozen in liquid nitrogen and stored at −80 ◦C. Paraffin-embedded
tissues were cut into 5 µm sections using a rotary microtome (Slee CUT 4060, Slee, Mainz, Germany),
deparaffinized and used for hematoxylin-eosin staining. Frozen tissues were cut on a cryostat (Leica CM
3050 S, Leica, Wetzlar, Germany) into 20 µm-sections and stained with oil red O stain. The Olympus®
BX-50 light microscope (Olympus, Tokyo, Japan), Olympus® C-5050 digital camera and QuickPHOTO
Pro software (Promicra s.r.o, Prague, Czech Republic) were used to obtain digital photographs. Images
of oil red O-stained tissue were processed and analyzed in FIJI software (FIJI is Just ImageJ), a
distribution of ImageJ2 open-source image processing software (Schindelin et al., 2012, 2015). Images
were transformed into black and white masks by adjusting the color balance, using Color transformer
2 plugin and image thresholding on the channel containing a signal from red-stained lipid droplets.
Lipid droplet area and total tissue area were measured in FIJI, and share of lipid droplet area was
calculated [70,71]. Blood vessels larger than liver sinusoids and artifacts were subtracted from the total
tissue area, if present on digital photographs. Three representative photographs were taken for each
animal under 40× objective, and after measurements, average values were calculated for each animal
and used for statistical analysis.
4.7. Ultrastructure
Tff3-deficient mouse strains on C57Bl6/NCrl were perfused with 4% PFA, and tissues were
immersion fixed immediately after removing in Ito’s fixative. Liver was post-fixed in OsO4, dehydrated
in a graded ethanol series, and whole tissues were embedded in Epon resin. Tissue sections (1 µm
thick) were cut with an ultramicrotome (Ultracut E; Reichert Jung, Vienna, Austria) and stained with
toluidine blue. Toluidine blue-stained slides were viewed and photographed with a Biorevo BZ-9000
microscope. Ultrathin sections of the tissue were cut, stained with uranyl acetate and lead citrate, and
viewed with a Transmission electron microscope (Jeol JEM-1400Plus).
5. Conclusions
The novel congenic mouse strain Tff3−/−/C57BL6NCrl is a valuable model for assessing the role of
Tff3 deficiency on liver disease relevant pathways. Here presented data show that Tff3 deficiency is not
crucial for acute ERS response caused by Tm. The impact of Tff3 deficiency in the liver can be seen at
the level of the transcriptional regulation of immune response relevant genes.
Since liver acts as an important metabolic and immunological organ, the influence of Tff3
deficiency and physiological function possibly reflects upon the whole organism. However, this has to
be determined in future investigations.
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Abbreviations
ACTB actin beta
ATF4 activating transcription factor 4
BIP endoplasmic reticulum chaperone bip
B2M beta-2-microglobulin
CHOP DNA damage-inducible transcript 3
COX1 cyclooxygenase I
CXCL1 C-X-C motif chemokine ligand 1
eIF2α eukaryotic translation initiation factor 2α
EDEM1 ER degradation enhancing alpha-mannosidase like protein 1
ER endoplasmic reticulum
ERS endoplasmic reticulum stress
GSTP1 glutathione S-transferase pi 1
GSTP2 glutathione S-transferase pi 2
GPX1 glutathione peroxidase 1
GRP94 heat shock protein 90 beta family member 1
IL1α interleukin 1 alpha
IL1β interleukin 1 beta
IL6 interleukin 6
MCP1 monocyte chemoattractant protein-1
MT1 metallothionein-1
MT2 metallothionein-1
NOX2 NADPH oxidase 2
PERK protein kinase R (PKR)-like endoplasmic reticulum kinase
SOD1 superoxide dismutase 1
SOD3 superoxide dismutase 3
sXBP1 spliced X-box binding protein 1
Tffs trefoil factor family proteins
TNFα tumor necrosis factor alpha
TGFα tumor growth factor alpha
Tm tunicamycin
UPR unfolded protein response
Wt wild type
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